<DOC>
	<DOCNO>NCT02757989</DOCNO>
	<brief_summary>Comparison survival patient without match donor 36 month</brief_summary>
	<brief_title>Allogeneic Hematopoietic Stem Cell Transplantation Patients With Myelodysplastic Syndrome Low Risk</brief_title>
	<detailed_description>Patients match donor ( 8/8 molecular level unrelated donor match sibling ) receive allogeneic hematopoietic stem cell transplantation . Patients without matched donor receive best available treatment . All patient follow least 36 month end study .</detailed_description>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>1 . Signed Informed consent 2 . All patient follow disease criterion together MDS classify accord classical IPSS intermediate 1 low MDS classify accord revise IPSS least intermediate Patients fail approved treatment EPO , lenalidomide Vidaza® eligible treatment thrombocytopenia &lt; 20 G/L require transfusion neutropenia &lt; 0.5 G/L associate severe infection ( define require hospitalization ) 3 . Age ≥ 45 &lt; 70 year 4 . Patient transplantation match donor , ( 8/8 ( HLA A , B , C , DRB1 ) identical molecular level ) unrelated donor match sibling ) , consider irrespective donor availability 5 . Performance status 02 Eastern Cooperative Oncology Group ( ECOG ) Scale ( At time screen ) 6 . Negative pregnancy adequate contraception ( include male patient wish father ) , relevant . 7 . Washout least 30 day since previous treatment Vidaza , Lenalidomide , EPO treatment induce cytopenia . 1 . MDS classify accord classical IPSS intermediate 2 High risk 2 . Transformation Acute myeloid Leukemia ( AML ) 3 . Severe active infection uncontrolled severe condition . 4 . Organ dysfunction include follow Hepatic : total bilirubin &gt; 2 time upper limit normal ( ULN ) ( except moderate unconjugated hyperbilirubinemia due intra medullary hemolysis Gilbert syndrome ) , alanine transaminase ( ALT ) aspartate transaminase ( AST ) &gt; 3xULN Symptomatic respiratory chronic failure Symptomatic cardiac failure Renal clearance &lt; 60ml/min 5 . Prior malignancy ( except situ cervix carcinoma , limited basal cell carcinoma , tumor active last 3 year )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Low risk MDS</keyword>
	<keyword>Transplantation</keyword>
</DOC>